- Trials with a EudraCT protocol (53)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
53 result(s) found for: Stage III Gastric Cancer.
Displaying page 1 of 3.
| EudraCT Number: 2009-011337-27 | Sponsor Protocol Number: AGMT Gastric-4 | Start Date*: 2010-05-03 | |||||||||||||||||||||
| Sponsor Name:AGMT | |||||||||||||||||||||||
| Full Title: A two-stage multicenter phase II trial of concurrent induction chemoimmunotherapy with epirubicine, oxaliplatin, capecitabine and panitumumab in KRAS wild-type, resectable type II gastric adenoca... | |||||||||||||||||||||||
| Medical condition: Gastric cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: AT (Prematurely Ended) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2015-000897-36 | Sponsor Protocol Number: AB14005 | Start Date*: 2016-04-26 | |||||||||||||||||||||
| Sponsor Name:AB science | |||||||||||||||||||||||
| Full Title: A prospective, multicentre, double-blind, randomized, placebo-controlled, phase 3 study to evaluate efficacy and safety of masitinib with irinotecan in patients with advanced-stage esophagogastric ... | |||||||||||||||||||||||
| Medical condition: Πatients with advanced-stage esophagogastric adenocarcinoma who have relapsed after first-line chemotherapy | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: GR (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2009-016468-35 | Sponsor Protocol Number: D8480C00067 | Start Date*: 2016-03-29 | |||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:AstraZeneca AB | |||||||||||||||||||||||||||||||||||||||||||
| Full Title: A randomised, double-blind, phase III efficacy and safety study of cediranib (RECENTIN™ ) when added to cisplatin plus a fluoropyrimidine, compared with cisplatin plus a fluoropyrimidine alone, in ... | |||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Gastric cancer | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GR (Completed) HU (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2008-007546-56 | Sponsor Protocol Number: NEO-FLOT | Start Date*: 2009-09-29 | ||||||||||||||||||||||||||
| Sponsor Name:Klinikum der Universität München, Campus Großhadern | ||||||||||||||||||||||||||||
| Full Title: A Phase II Multicentre Study of perioperative Chemotherapy for resectable Adenocarcinoma of the Gastroesophageal Junction and of the Stomach | ||||||||||||||||||||||||||||
| Medical condition: Resectable Adenokarcinoma of the Gastroesophageal Junction and of the Stomach | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||
| EudraCT Number: 2015-003301-42 | Sponsor Protocol Number: EMR100070-008 | Start Date*: 2016-05-19 | |||||||||||||||||||||||||||||||
| Sponsor Name:Merck KGaA | |||||||||||||||||||||||||||||||||
| Full Title: A Phase III open-label, multicenter trial of avelumab (MSB0010718C) as a third-line treatment of unresectable, recurrent, or metastatic gastric or gastroesophageal junction adenocarcinoma | |||||||||||||||||||||||||||||||||
| Medical condition: Unresectable, recurrent, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: DE (Completed) BE (Completed) ES (Completed) CZ (Completed) FR (Completed) PL (Completed) IT (Completed) | |||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2006-006088-22 | Sponsor Protocol Number: Gastripec-I | Start Date*: 2011-03-28 | ||||||||||||||||
| Sponsor Name:Klinik für Chirurgie, Charité Campus Virchow-Klinikum | ||||||||||||||||||
| Full Title: Prospective multicenter phase III clinical trial using cytoreductive surgery with hyperthermic intraoperative chemotherapy (HIPEC) after preoperative chemotherapy in patients with peritoneal carc... | ||||||||||||||||||
| Medical condition: Peritoneal carcinomatosis of gastric cancer incl. adenocarcinoma of the esophagogastreal junction | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2010-023377-19 | Sponsor Protocol Number: D2610C00004 | Start Date*: 2011-11-03 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:AstraZeneca | ||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: A Randomised Open-Label Phase II Study to Assess the Efficacy & Safety of AZD4547 Monotherapy versus Paclitaxel in Patients with Advanced Gastric Adenocarcinoma (inc. Adenocarcinoma of the Lower Th... | ||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: FGFR, Amplification, polysomy, gastro-oesophageal junction cancer, lower third oesophageal cancer, gastric cancer, randomised, efficacy | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GB (Completed) DE (Completed) CZ (Completed) ES (Completed) BE (Completed) IT (Completed) HU (Completed) BG (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2015-003300-23 | Sponsor Protocol Number: EMR100070-007 | Start Date*: 2016-06-13 | |||||||||||||||||||||||||||||||
| Sponsor Name:Merck KGaA | |||||||||||||||||||||||||||||||||
| Full Title: A Phase III open-label, multicenter trial of maintenance therapy with avelumab (MSB0010718C) versus continuation of first-line chemotherapy in subjects with unresectable, locally advanced or metas... | |||||||||||||||||||||||||||||||||
| Medical condition: Advanced (unresectable, locally advanced or metastatic) adenocarcinoma of the stomach, or of the gastro-esophageal junction (GEJ) | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) HU (Completed) RO (Completed) DE (Completed) ES (Completed) FR (Completed) IT (Completed) | |||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2014-003039-20 | Sponsor Protocol Number: COMAN | Start Date*: 2014-11-28 | |||||||||||||||||||||
| Sponsor Name:A. O. Istituti Ospitalieri di Cremona | |||||||||||||||||||||||
| Full Title: RANDOMIZED PHASE II STUDY WITH SEQUENTIAL NON-CROSS RESISTANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED INOPERABLE OR METASTATIC GASTRO-ESOPHAGEAL ADENOCARCINOMA | |||||||||||||||||||||||
| Medical condition: Locally advanced inoperable or metastatic gastro-esophageal adenocarcinoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2007-004693-34 | Sponsor Protocol Number: GOIRC 02/2007 | Start Date*: 2007-12-20 | |||||||||||
| Sponsor Name:GRUPPO ONCOLOGICO ITALIANO DI RICERCA | |||||||||||||
| Full Title: Multicenter, phase II study of chemotherapy with dose-dense modified TCF in locally advanced or metastatic gastric cancer. | |||||||||||||
| Medical condition: Patients with locally advanced or metastatic gastric cancer. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-000175-42 | Sponsor Protocol Number: BO20904 | Start Date*: 2007-12-21 | |||||||||||
| Sponsor Name:F. Hoffmann-La Roche Ltd. | |||||||||||||
| Full Title: A double-blind, randomised, multicenter, phase III study of bevacizumab in combination with capecitabine and cisplatin versus placebo in combination with capecitabine and cisplatin, as first-line t... | |||||||||||||
| Medical condition: Adult and elderly patients with histologically confirmed, inoperable, locally advanced or metastatic adenocarcinoma of the stomach or gastro-oesophageal junction, who have received no prior treatme... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) ES (Completed) GB (Completed) DE (Completed) IT (Completed) | |||||||||||||
| Trial results: Removed from public view | |||||||||||||
| EudraCT Number: 2015-004627-31 | Sponsor Protocol Number: M15CRI | Start Date*: 2017-06-20 | |||||||||||||||||||||
| Sponsor Name:The Netherlands Cancer Institute | |||||||||||||||||||||||
| Full Title: A multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery vs. neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery vs. neo-adjuvant chemorad... | |||||||||||||||||||||||
| Medical condition: TNM 7th ed stage IB-IIIC gastric adenocarcinoma (histologically proven); tumour bulk has to be in the stomach but may involve gastro-oesophageal junction | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: NL (Trial now transitioned) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2014-003791-23 | Sponsor Protocol Number: I4T-MC-JVDB | Start Date*: 2015-04-23 | |||||||||||
| Sponsor Name:Eli Lilly and Company | |||||||||||||
| Full Title: Protocol I4T-MC-JVDB Randomized Phase 2 Trial Evaluating Pharmacokinetics and Safety of Four Ramucirumab Dosing Regimens in Second Line Gastric or Gastroesophageal Junction Adenocarcinoma | |||||||||||||
| Medical condition: Second Line Gastric or Gastroesophageal Junction Adenocarcinoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) SK (Completed) FR (Completed) PL (Completed) RO (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-007798-18 | Sponsor Protocol Number: AIO/CAO-STO-0801 | Start Date*: 2010-07-01 | ||||||||||||||||
| Sponsor Name:AIO-Studien-gGmbH | ||||||||||||||||||
| Full Title: An Open Label Randomized Controlled Phase II Trial of Panitumumab in Combination with Epirubicin, Cisplatin and Capecitabine (ECX) versus ECX Chemotherapy alone in Subjects with Locally Advanced Ga... | ||||||||||||||||||
| Medical condition: Subjects with Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2020-004636-25 | Sponsor Protocol Number: ACOTAS_G098 | Start Date*: 2021-06-17 | ||||||||||||||||
| Sponsor Name:GERCOR | ||||||||||||||||||
| Full Title: A phase II study to evaluate the rate of cardiovascular events during trifluridine/tipiracil +/-oxaliplatin treatment in colorectal/oesogastric adenocarcinoma patients that have experienced a pas... | ||||||||||||||||||
| Medical condition: colorectal or oesogastric adenocarcinoma | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FR (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2014-005067-32 | Sponsor Protocol Number: I4T-MC-JVCZ | Start Date*: 2015-11-24 | |||||||||||
| Sponsor Name:Eli Lilly and Company | |||||||||||||
| Full Title: Protocol I4T-MC-JVCZ Randomized Phase 2 Trial Evaluating Alternative Ramucirumab Doses in Combination with Paclitaxel in Second-Line Metastatic or Locally Advanced, Unresectable Gastric or Gast... | |||||||||||||
| Medical condition: Second-Line Metastatic or Locally Advanced, Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) CZ (Completed) SE (Completed) GR (Completed) BE (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-024111-13 | Sponsor Protocol Number: AIO-STO-0110 | Start Date*: 2011-04-15 | |||||||||||||||||||||
| Sponsor Name:AIO-Studien-gGmbH | |||||||||||||||||||||||
| Full Title: Explorative trial to investigate catumaxomab (anti-EpCAM x anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric adenocarcinomas prior to gastrectomy | |||||||||||||||||||||||
| Medical condition: Gastric adenocarcinoma and carcinoma of the esophago-gastric junction (type II and type III according to Siewert’s classification) prior to gastrectomy, with peritoneal carcinomatosis. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2010-018993-20 | Sponsor Protocol Number: P-FLOT | Start Date*: 2011-01-26 | |||||||||||||||||||||
| Sponsor Name:Universitätsklinikum Schleswig-Holstein, Campus Kiel | |||||||||||||||||||||||
| Full Title: Multicenter phase II study of panitumumab, docetaxel, 5-FU, leucovorin and oxaliplatin (P-FLOT) in patients with metastatic or locally advanced Kras wild type adenocarcinoma of the stomach or the g... | |||||||||||||||||||||||
| Medical condition: Adenocarcinoma of the stomach or the gastroesophageal junction | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2018-002014-13 | Sponsor Protocol Number: PRODIGE59-(FFCD1707)-DURIGAST | Start Date*: 2018-11-27 | ||||||||||||||||
| Sponsor Name:Fédération Francophone de Cancérologie Digestive | ||||||||||||||||||
| Full Title: A randomized phase II study evaluating FOLFIRI + durvalumab vs FOLFIRI + durvalumab and tremelimumab in second-line treatment of patients with advanced gastric or gastro-oesophageal junction adenoc... | ||||||||||||||||||
| Medical condition: Advanced gastric or gastro-oesophageal junction adenocarcinoma | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FR (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2005-004280-31 | Sponsor Protocol Number: 04/280507 | Start Date*: 2006-02-02 |
| Sponsor Name:University of Dundee | ||
| Full Title: Hyperthermic Intraperitoneal Chemotherapy - Gastric Cancer | ||
| Medical condition: Gastric Cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
